What Researchers Did
Researchers presented a case of delayed ischaemic complication from a hyaluronic acid filler injection that was treated with hyaluronidase and hyperbaric oxygen therapy.
What They Found
A patient experienced ischaemic wound and mucosal necrosis within hours of a hyaluronic acid facial injection, but diagnosis and treatment were delayed for 5 days. Treatment included hyaluronidase followed by 14 daily sessions of hyperbaric oxygen therapy (HBOT). Despite the delay, the patient achieved essentially complete recovery.
What This Means for Canadian Patients
Canadian patients experiencing delayed complications from cosmetic filler injections may still achieve good recovery with appropriate treatment. This case suggests that hyperbaric oxygen therapy could be a valuable adjunct to hyaluronidase, even when treatment is not immediate.
Canadian Relevance
This case study was authored by Canadian researchers, indicating direct relevance to Canadian medical practice and patient care.
Study Limitations
As a single case report, the findings cannot be generalized to a broader patient population.